Roles of homocysteine in cell metabolism: Old and new functions

European Journal of Biochemistry

Volumn 268, Issue 14, 2001, Pages 3871-3882

  Medina, Miguel Á ^a   Urdiales, José L ^a   Amores Sánchez, María I ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Cardiovascular disease; Cobalamine; Folate; Homocysteine; Neural tube deffect; Protein homocysteinylation

Indexed keywords

HOMOCYSTEINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; TETRAHYDROFOLIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR AP 1;

AMINO ACID METABOLISM; BLOOD LEVEL; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CARDIOVASCULAR RISK; CELL METABOLISM; DEVELOPMENTAL DISORDER; ENZYME SYNTHESIS; HUMAN; HYPERHOMOCYSTEINEMIA; MEDICAL RESEARCH; METHYLATION; NEURAL CREST; NEURAL TUBE; NONHUMAN; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SOLUTIO PLACENTAE; SPINA BIFIDA; SPONTANEOUS ABORTION; VEIN THROMBOSIS;

CARDIOVASCULAR DISEASES; CELL PHYSIOLOGY; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; METHIONINE; METHYLATION; NERVOUS SYSTEM MALFORMATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; RNA, TRANSFER, AMINO ACYL; S-ADENOSYLMETHIONINE;

EID: 0034837955     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2001.02278.x     Document Type: Review

References (136)

1. Homocysteine and cardiovascular disease
2. Homocysteine and vascular disease
3. Homocysteine: An emergent cardiovascular risk factor?
4. Homocysteine: A history in progress
5. Methionine metabolism in mammals
6. Inactivation of betaine-homocysteine methyltransferase by adenosylmethionine and adenosylethionine
7. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine
8. A novel pathway for the conversion of homocysteine to methionine in eukaryotes
9. Protein homocysteinylation: Possible mechanism underlying pathological consequences of elevated homocysteine levels
10. A candidate genetic risk factor for cardiovascular disease: A common mutation in methylenetetrahydrofolate reductase
11. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement
12. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis
13. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry
14. Characterization of homocysteine metabolism in the rat kidney
15. Homocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
16. No net renal extraction of homocysteine in fasting humans
17. Photoaffinity labeling of methylenetetrahydrofolate reductase with 8-azido-S-adenosylmethionine
18. Methionine metabolism in mammals: Distribution of homocysteine between competing pathways
19. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine
20. Homocysteine metabolism
21. Hypomethylation as a cause of homocysteine-induced cell damage in human cell lines
22. Relationship between tissue levels of S-adenosylmethionine, S-adenyl-homocysteine, and transmethylation reactions
23. Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications
24. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation
25. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease
26. ras methylation in vascular endothelial cells by homocysteine but not cysteine
27. D-Amino acids in aging erythrocytes
28. Adverse effects of hyperhomocysteinemia and their management by folic acid
29. Nuclear accumulation of S-adenosylhomocysteine hydrolase in transcriptionally active cells during development of Xenopus laevis
30. Crystal structure of S-adenosylhomocysteine hydrolase from rat liver
31. Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells
32. Translational incorporation of S-nitroso-homocysteine into protein
33. Metabolism of homocysteine thiolactone in human cell cultures: Possible mechasmism for pathological consequences of elevated homocysteine levels
34. Calcium-dependent human serum homocysteine thiolactone hydrolase
35. In vitro kinetic studies of the formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways
36. Alzheimer's disease. A glycation connection
37. Mechanisms of homocysteine toxicity on connective tissues: Implications for the morbidity of aging
38. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells. Implications for atherosclerosis
39. Total homocysteine in plasma or serum: Methods and clinical applications
40. Methionine synthase inactivation by nitrous oxide during methionine loading of normal human fibroblasts. Homocysteine remethylation as determinant of enzyme inactivation and homocysteine export
41. Diagnosis of cobalamin deficiency. 1. Usefulness of serum methylmalonic acid and total homocysteine concentrations
42. Impaired homocysteine metabolism in early-onset cerebral an peripheral occlusive arterial disease - Effects of pyridoxine and folic acid treatment
43. Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrations
44. Homocysteine and vitamins in cardiovascular disease
45. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy
46. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland
47. The identification of homocysteine in the urine
48. Homocystinuria: An enzymatic defect
49. Inherited disorders of vitamin-B12 utilization
50. Effects of ingestion of disproportionate amounts of amino acids
51. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
52. Homocysteine theory of arteriosclerosis
53. The pathogenesis of coronary artery disease. A possible role for methionine metabolism
54. Hyperhomocysteinemia: An independent risk factor for vascular disease
55. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
56. Serum folate and risk of fatal coronary heart disease
57. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
58. Plasma homocysteine levels and mortality in patients with coronary artery disease
59. Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes
60. Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons
61. Increased plasma homocysteine is an independent predictor of new coronary events in older persons
62. The controversy over homocysteine and cardiovascular risk
63. Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis
64. Homocysteine: More questions than answers
65. Homocysteine as atherothrombotic agent: Is the bark worse than the bite?
66. Homocysteine and cardiovascular risk
67. Homocysteine and cardiovascular disease: Cause or effect?
68. Endpoints for homocysteine-lowering trials
69. 6 on progresssion of subclinical atherosclerosis: A rondomised, placebo-controlled trial
70. Homocysteine and lipid metabolism in atherogenesis: Effect of homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide
71. The oxidation hypothesis of atherosclerosis
72. Redox status of plasma homocysteine and other plasma thiols in stroke patients
73. Homocysteinemia: Vascular injury and arterial thrombosis
74. Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis
75. The pathogenesis of atherosclerosis: A perspective for the 1990s
76. Developmental mechanisms underlying pathology of arteries
77. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
78. Homocysteine catabolism: Levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease
79. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
80. Atherosclerosis
81. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
82. Homocysteine and thrombotic disease
83. Homocysteine and other sulfhydryl compounds enhances the binding of lipoprotein (a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism
84. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
85. Lowered antitrombina III activity and other clotting changes in homocystinuria. Effects of a pyridoxine-folate regimen
86. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells
87. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells
88. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor
89. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator
90. Biological chemistry of thiols in the vasculature and in vascular-related disease
91. Characterization of the stress-inducing effects of homocysteine
92. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface
93. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins
94. Changes in the intracellular homocysteine and glutathione content associated with aging
95. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species
96. A model for p53-mediated apoptosis
97. Can ends justify the means? Telomeres and the mechanism of replicative senescence and immortalization in mammalian cells
98. Homocysteine accelerates endothelial cell senescence
99. Mutated methylene-tetrahydrofolate reductase as a risk factor for spina bifida
100. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: Results from a population-based, case-control study
101. Primary prevention of neural tube defects with folic acid
102. Maternal periconceptinal use of multi-vitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring
103. Folic acid metabolism and mechanisms of neural tube defects
104. Maternal hyperhomocysteinemia: A risk factor for neural-tubed defects?
105. Homocysteine induces congenital heart and neural tube defects. Effect of folic acid
106. Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture
107. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor
108. Dextromethorphan and other N-methyl-D-aspartate receptor antagonists are teratogenic in the avian embryo model
109. N-Methyl-D-aspartate receptor agnoists modulate homocysteine-induced developmental abnormalities
110. Hyperhomocysteinemia and pregnancy review of our present undestanding and therapeutic implications
111. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss
112. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss
113. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis
114. Is oxidative stress the link in the two-stage model of preeclampsia?
115. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction
116. Underlying disorders associated with severe early onset preeclampsia
117. Elevated homocysteine levels with preeclampsia
118. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation
119. Inherited thrombophilic states
120. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: A new role for homocysteine in liver fibrosis
121. Homocysteine exerts cell type-specific inhibition of AP-1 transcription factor
122. Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine
123. Plasma homocysteine in children with acute lymphoblastic leukemia. Changes during a chemotherapeutic regimen including methotrexate
124. Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?
125. Homocysteine and Alzheimer's disease
126. Homocysteine, Alzheimer;s disease, and cognitive function
127. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
128. Relations of vitamin B-12, vitamin B-6, folate and homocysteine to cognitive performance in the Normative Aging Study
129. Total serum homocysteine in senile dementia of Alzheimer type
130. Homocysteine correlates with cognitive function in the Sacramento Area Latino Study of Aging (SALSA)
131. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study
132. Elevated plasma homocysteine levels in centenarians are not associated with cognitive impairment
133. B vitamins, homocysteine and neurocognitive function in the elderly
134. Vascular risk factors for Alzheimer's disease: An epidemiologic perspective
135. Plasma homocysteine concentrations are positively associated with hostility and anger